The contribution of human conflict to the development of antimicrobial resistance

Scott J C Pallett; Sara E Boyd; Matthew K O'Shea; Jessica Martin; David R Jenkins; Emma J Hutley

doi:10.1038/s43856-023-00386-7

The contribution of human conflict to the development of antimicrobial resistance

Commun Med (Lond). 2023 Oct 25;3(1):153. doi: 10.1038/s43856-023-00386-7.

Authors

Scott J C Pallett¹, Sara E Boyd², Matthew K O'Shea³, Jessica Martin⁴, David R Jenkins⁵, Emma J Hutley³

Affiliations

¹ Centre of Defence Pathology, Royal Centre for Defence Medicine, Queen Elizabeth Hospital, Birmingham, UK. scott.pallett@nhs.net.
² Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, L69 3GE, UK.
³ Centre of Defence Pathology, Royal Centre for Defence Medicine, Queen Elizabeth Hospital, Birmingham, UK.
⁴ Department of Clinical Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds, LS1 3EX, UK.
⁵ Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Infirmary Square, Leicester, LE1 5WW, UK.

Abstract

Human conflict, such as the ongoing conflict in Ukraine, is an important driver of antimicrobial resistance. Here, we describe the challenges when addressing this problem during an ongoing conflict and the opportunities available to reduce the spread of antimicrobial resistance.